Colorectal Cancer With High Tumor Mutational Burden and Mesenchymal-Epithelial Transition (MET) Amplification With Hyperprogressive Disease After Pembrolizumab Treatment. - Nakajima S; Sasaki A; Okamoto R (Cureus, 2025)